Board of Directors

  • tb_bon.jpg

    Björn O. Nilsson Chairman of the Board

    Doctor of Science. Born 1956. Lives in Sollentuna, Sweden. Professor, CEO and member of the Royal Swedish Academy of Engineering Sciences. Associate professor at the Royal Institute of Technology (KTH) in Stockholm. Member of the Board since 1999. Chairman of the Board since 2011. Chairman of the Remuneration Committee. Member of the Audit Committee.

    Other board appointments: 

    Chairman of the Board of the Ångpanneföreningen's Foundation for Research and Development and Stockholm Science City. Member of the Boards of ÅF AB, Sveriges Utbildningsradio AB, SwedNanoTech AB and Högskolan i Gävle.

    Shareholding: 54,474

  • tb_va.jpg

    Vessela Alexieva Employee representative

    M.Sc. Molecular and functional biology. Born 1959 Lives in Lund, Sweden. Research Engineer. Member of the Board since 2013.

    Other board appointments: 

    -

    Shareholding: 20,850 (own and affiliated holdings)

    Options: Employee options: 5,250

  • avej2016.jpg

    An van Es Johansson

    M.D. Born 1960. Lives in Stockholm, Sweden. Vice President Swedish Orphan Biovitrum AB (Sobi), Head of EMENAR Medical och SCPP Medical and member of the Scientific Advisory Board Uppsala Bio. Previously several positions within Sobi (Biovitrum AB), i.a. Head of Medical, Head of Clinical Development and Head of Clinical Science, and previous positions within Drug Development and Commercial at Roche and Pharmacia & Upjohn. Member of the BioInvent Board since 2016.

    Other board appointments: 

    -

    Shareholding: -

  • tb_lin.jpg

    Lars Ingelmark

    Bachelor of Medicine. Born 1949. Lives in Halmstad, Sweden. Consul of Luxembourg. Member of the Board since 2006. Chairman of the Audit Committee.

    Other board appointments: 

    Chairman of the Board of Svensk Våtmarksfond. Member of the Boards of Gyttorp AB and Svenska Jägareförbundet.

    Shareholding: 2,539

  • lkm2016.png

    Leonard Kruimer

    MBA. Born 1958. Lives in Rotterdam, Netherlands. CFO and acting CEO of to-BBB Holding B.V.. Former CFO and acting CEO of to-BBB Holding B.V., Former CFO and board member of Crucell N.V. 1998-2011, chairman of supervisory board of Profibrix B.V., several earlier executive positions, consultant with McKinsey & Company and auditor with Price Waterhouse & Company. Member of the BioInvent Board since 2016. Member of the Remuneration Committee.

    Other board appointments: 

    -

    Shareholding: -

  • mnn2016.png

    Martin Nicklasson

    Pharm. PhD. Born 1955. Lives in Västra Frölunda, Sweden. Associate Professor at the Faculty of Pharmacy, Uppsala University. Former CEO of Swedish Orphan Biovitrum AB 2007-2010. Several positions with Astra/AstraZeneca, including responsible for global drug development and marketing and business development with AstraZeneca Ltd., and CEO of AstraZeneca Sweden AB. CEO of Astra Hässle AB and responsible for R&D within KABI. Member of the BioInvent Board since 2016. Member of the Audit Committee.

    Other board appointments: 

    Chairman of the Board of Orexo AB, Zealand Pharma A/S and Farma Investment AS. Member of the Boards of Basilea Pharmaceutical Ltd., PledPharma AB, Premier Research Group Ltd and Biocrine AB.

    Shareholding: 21,000

  • vow2016.png

    Vincent Ossipow

    CFA, Ph.D. Born 1968. Lives in Commugny, Switzerland. Venture partner Omega Funds. Former partner Private Equity Sectoral Asset Management. Researcher at University of Geneva. Research analyst at Pictet Bank. Member of the BioInvent Board since 2016. Member of the Audit Committee.

    Other board appointments: 

    Member of the Boards of Andrew Alliance, Kuros Biosciences, Etherna Immunotherapies and Sophia Genetics.

    Shareholding: -

  • tb_utm.jpg

    Ulrika T. Mattson Employee representative

    University degree in Biomedical Laboratory Science. Born 1968 Lives in Malmö, Sweden. Biomedical Scientist. Member of the Board since 2007.

    Other board appointments: 

    -

    Shareholding: 400 (own and affiliated holdings)

    Options: Employee options: 5,250 Stock options: 50,000

  • bsg.jpg

    Birgitta Stymne Göransson

    MBA, Harvard Business School and M.Sc. in Biotechnology from the Royal Institute of Technology in Stockholm. Born 1957. Lives in Stockholm. Former CEO of the Memira Group, CEO of Semantix, and Deputy CEO of Telefosgruppen. Member of the Board since 2015. Member of the Remuneration Committee.

    Other board appointments: 

    Chairman of the Board of Medivir AB, HL Display AB and Fryshuset Foundation. Member of the Boards of Elekta AB, Rhenman & Partners Asset Management AB, Midsona AB and Pandora A/S.

    Shareholding: 89,600